Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Latest press releases
- Local budding biologists explore the past, present and future during GSK Science in the Summer™ in partnership with the Franklin Institute
- GSK delivers strong Q1 2022 sales of £9.8 billion, +32% AER, +32% CER; Total EPS 35.9p +67% AER, +66% CER and Adjusted EPS 32.8p +43% AER, +43% CER
- US Food and Drug Administration accepts New Drug Application for daprodustat
- GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
GSK US Twitter
-
GSKUS @GSKUS
This #AsthmaAwarenessMonth, we are highlighting the importance of discussing the full impact of asthma symptoms. If you have more questions after speaking to your doctor, consider working with a health educator to gain more understanding. @BREATHESOCAL
about 2 days ago -
GSKUS @GSKUS
#LupusAwarenessMonth is a time to educate and empower the #lupus community. We are proud partners of @LupusOrg as we continue to raise awareness of this chronic disease. Together, our shared ambition can make a difference in millions of lives impacted by lupus.
about 4 days ago
-
GSK in the US
The US is home to ~15,000 GSK employees across 50 states, 9 manufacturing facilities and multiple R&D centers.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Consumer Healthcare develops brands in Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
